Noah C. Federman, MD
Accepting new patients

Noah C. Federman, MD

  • Pediatric Hematology Oncology

About

Dr. Noah Federman is the Director of the Pediatric Bone and Soft Tissue Sarcoma Program at UCLA, part of the UCLA Sarcoma Program and UCLA's Jonsson Comprehensive Cancer Center. Dr. Federman specializes in treating children, adolescents and young adults with these aggressive cancers. He runs a incredibly comprehensive and & multidisciplinary program involving pediatric and medical oncologists, radiation oncologists, orthopedic oncology surgeons, musculoskeletal radiologists and pathologists, nuclear medicine specialists, physical therapists and prosthetic specialists. Dr. Federman also specializes in conducting clinical trials and leads an experienced clinical research team devoted to providing access to clinical trials for children with refractory, recurrent and metastatic bone and soft tissue cancers.

For new patients or consultations speak to Margie Weiman, Pediatric Bone and Soft Tissue Sarcoma Nurse Case Manager.

Business Office
1250 16th Street, Suite 3145
Santa Monica, CA 90404

Languages

English

Education

Medical Board Certification

Pediatric Hematology-Oncology, American Board of Pediatrics, 2009

Fellowship

Pediatric Hematology-Oncology, UCLA School of Medicine, 2008

Residency

Pediatrics, UCLA School of Medicine, 2005

Internship

Pediatrics, UCLA School of Medicine, 2003

Degree

MD, Icahn School of Medicine at Mount Sinai, 2002

Hospital Affiliations

Research

Publications

  1. Federman N, Bernthal N, Eilber FC, Tap WD. The Multidisciplinary Management of Osteosarcoma. Curr Treat Options Oncol. 2009 Feb 24. [Epub ahead of print]
  2. Benz MR, Tchekmedyian N, Eilber FC, Federman N, Czernin J, Tap WD. Utilization of positron emission tomography in the management of patients with sarcoma. Curr Opin Oncol. 2009 Jul;21(4):345-51.
  3. Federman N, Sakamoto K. Nonrhabdomyosarcoma soft tissue sarcomas. Emedicine. Dec 2008.
  4. Tap WD, Federman N, Eilber FC. Targeted therapies for soft-tissue sarcomas. Expert Rev Anticancer Ther. 2007 May;7(5):725-33.
  5. Federman N, Feig SA. PET/CT in evaluating pediatric malignancies: a clinician's perspective. J Nucl Med. 2007 Dec;48(12):1920-2.

Insurance

  • Aetna
  • Anthem Blue Cross
  • Blue Shield of California
  • Centivo
  • Cigna
  • First Health
  • Health Net of California
  • Interplan (part of HealthSmart)
  • L.A. Care
  • Medicare Advantage
  • MultiPlan
  • UFCM Health System
  • Prime Health Services
  • Private Healthcare Systems (PHCS)
  • TRICARE
  • UnitedHealthcare

The list of health care plans above may not be comprehensive and could change. 
Please contact your benefits coordinator or health insurance company directly to verify coverage.

Visit our health insurance information page for more details.

Recognitions